Keimyung University Dongsan Hospital

Dalseogu, Daegu Gwang'yeogsi 42601

1 studies enrolling now · 4 studies all time

What they study most

Esophageal Squamous Cell Carcinoma (ESCC), HR+/HER2- Breast Cancer, Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, NSCLC, Non-small Cell Lung Cancer

Studies at this site

• BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease — Recruiting now
• A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma — Running, not enrolling
• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma — Completed